24 March 2024>: Clinical Research
Psychological and Physical Well-Being in Women Diagnosed with Breast Cancer: A Comprehensive Study of Anxiety, Depression, Sleep Quality, Physical Activity, and Sociodemographic Factors
Oliver J. Czech 1ABCDEFG* , Rafał Matkowski 23BEG , Jakub Skórniak 2BE , Iwona Malicka 1ABCDEFGDOI: 10.12659/MSM.943490
Med Sci Monit 2024; 30:e943490
Table 4 Results of regression for depression.
Variables | b | SE b | 95% CI | t | P | F | P | R2 | ΔR2 | |
---|---|---|---|---|---|---|---|---|---|---|
LL | UL | |||||||||
18.01 | 0.17 | 0.17 | ||||||||
Breast cancer | 5.66 | 1.33 | 3.01 | 8.31 | 4.25 | |||||
7.11 | 0.25 | 0.08 | ||||||||
Breast cancer | 4.24 | 1.37 | 1.48 | 7.00 | 4.25 | |||||
Sleep efficacy | −0.12 | 0.06 | −0.23 | 0.00 | −2.01 | 0.047 | ||||
PA level (sufficient) | −3.51 | 1.56 | −6.62 | −0.40 | −2.25 | 0.03 | ||||
PA level (high) | −3.13 | 1.74 | −6.59 | 0.33 | −1.80 | 0.08 | ||||
4.87 | 0.29 | 0.04 | ||||||||
Breast cancer | 1.06 | 3.47 | −5.83 | 7.96 | 0.31 | 0.76 | ||||
Sleep efficacy | −0.13 | 0.06 | −0.24 | −0.01 | −2.15 | 0.04 | ||||
PA level (sufficient) | −3.44 | 1.58 | −6.57 | −0.30 | −2.18 | 0.03 | ||||
PA level (high) | −3.09 | 1.72 | −6.51 | 0.33 | −1.80 | 0.08 | ||||
ER+ | 2.93 | 3.47 | −3.97 | 9.82 | 0.84 | 0.40 | ||||
PR+ | −0.66 | 2.66 | −5.95 | 4.63 | −0.25 | 0.80 | ||||
HER2+ | 5.51 | 2.71 | 0.11 | 10.91 | 2.03 | 0.045 | ||||
4.38 | 0.30 | 0.01 | ||||||||
Breast cancer | 0.56 | 3.51 | −6.42 | 7.53 | 0.16 | 0.87 | ||||
Sleep efficacy | −0.13 | 0.06 | −0.24 | −0.01 | −2.15 | 0.04 | ||||
PA level (sufficient) | −3.80 | 1.62 | −7.02 | −0.58 | −2.35 | 0.02 | ||||
PA level (high) | −3.43 | 1.76 | −6.92 | 0.06 | −1.95 | 0.05 | ||||
ER+ | 3.18 | 3.48 | −3.74 | 10.10 | 0.91 | 0.36 | ||||
PR+ | −0.47 | 2.67 | −5.78 | 4.84 | −0.18 | 0.86 | ||||
HER2+ | 5.91 | 2.75 | 0.45 | 11.38 | 2.15 | 0.03 | ||||
Age | −0.07 | 0.07 | −0.20 | 0.07 | −0.98 | 0.33 | ||||
SE – standard error; CI – confidence intervals; LL – lower limit; UL – upper limit; PA – physical activity; ER+ – positive estrogen receptor expression; PR+ – positive progesterone receptor expression; HER2+ – human epidermal growth factor receptor 2 positive breast cancer. |